Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | SIYA AGENCIESLikely | RA Ended | 2 | ₹32,820.48 |
| 2 | Schedule 2 | SIYA AGENCIES | Awarded | 1 | ₹20,088 |
| 3 | Schedule 3 | SAI KIRPA SURGICALS | Awarded | 1 | ₹75,787.20 |
| 4 | Schedule 4 | SIYA AGENCIES | Awarded | 1 | ₹2.9 L |
| 5 | Schedule 5 | M/S KANISHKA PHARMACEUTICALS | Awarded | 1 | ₹3.0 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
19 Nov 2024, 2:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Brimonidine Tartrate 0.2Percent Eye drops 5ml
Eye Drop Brimonidine LS 0.1Percent Plus TIMOLOL 0.5Percent
Brinzolamide 1.0Percent bott of 5 ml Eye drops
E D Brinzolamide 1Percent with Brimodine 0.2Percent with Mannitol bott of 5 ml
MDI Glycopyrrolate 9 mcg Plus Formoterol Fumarate 4.8 mcg with dose counter
MDI Glycopyrrolate IP9 mcg PlusFormoterol Fumarate 4.8 mcg Plus Budesonide IP160 mcg
Rotacap Glycopyrronium Bromide USP 25 mcg Plus Formeterol Fumarate Dihydrate IP6 mcg
Tab Vitamin B Complex
7047785
GEM/2024/B/5527346
Two Packet Bid
Brimonidine Tartrate 0.2Percent Eye drops 5ml,Eye Drop Brimonidine LS 0.1Percent Plus TIMOLOL 0.5Pe
30 days
Uttarakhand; Dehradun
Item wise evaluation
BOQ
6 documents required · 6 mandatory
Exempted
19 Nov 2024
29 Oct 2024
19 Nov 2024
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Brimonidine Tartrate 0.2Percent Eye drops 5ml | Brimonidine Tartrate 0.2Percent Eye drops 5ml | 1,332 | Bottle | DEHRADUN | 30 |
| 2 | Eye Drop Brimonidine LS 0.1Percent Plus TIMOLOL 0.5Percent | Eye Drop Brimonidine LS 0.1Percent Plus TIMOLOL 0.5Percent | 648 | No | DEHRADUN | 30 |
| 3 | Brinzolamide 1.0Percent bott of 5 ml Eye drops | Brinzolamide 1.0Percent bott of 5 ml Eye drops | 684 | Bottle | DEHRADUN | 30 |
| 4 | E D Brinzolamide 1Percent with Brimodine 0.2Percent with Mannitol bott of 5 ml | Eye Drop Brinzolamide 1Percent with Brimodine 0.2Percent with carbomer 974 P and Mannitol bott of 5 ml | 840 | Bottle | DEHRADUN | 30 |
| 5 | MDI Glycopyrrolate 9 mcg Plus Formoterol Fumarate 4.8 mcg with dose counter | MDI Glycopyrrolate 9 mcg Plus Formoterol Fumarate 4.8 mcg with dose counter | 705 | No | DEHRADUN | 30 |
| 6 | MDI Glycopyrrolate IP9 mcg PlusFormoterol Fumarate 4.8 mcg Plus Budesonide IP160 mcg | MDI Glycopyrrolate IP 9 mcg Plus Formoterol Fumarate 4.8 mcg Plus Budesonide IP 160 mcg with Dose countre | 660 | No | DEHRADUN | 30 |
| 7 | Rotacap Glycopyrronium Bromide USP 25 mcg Plus Formeterol Fumarate Dihydrate IP6 mcg | Rotacap Glycopyrronium Bromide USP equivalent to Glycopyrronium 25 mcg Plus Formeterol Fumarate Dihydrate IP Equivalent to Formoterol Fumarate 6 mcg | 900 | Pack | DEHRADUN | 30 |
| 8 | Tab Vitamin B Complex | Tab Vitamin B Complex Prophylactic each containing Thiamine monoitrate IP 2 mg riboflavin 2 mg pyridoxine HCL IP 0.5 mg Niacinamide IP 25 mg calcium pantothenate IP 1 mg | 3,21,660 | No | DEHRADUN | 30 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7047785.pdf
GEM_BID
docscanner_noting_re-781_2024-10-21-11-50-30_9146cc69c8cbe83bf81c4bbd5b51bf63.pdf
BOQ
boq_echs-781_2024-10-21-11-50-30_0a58d9971f6f895e5271b18e69a30461.csv
BOQ
Undertking_8b24891b-ae9b-4742-b7e21729492834159_hempreet@1234.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .